Supported by the National Natural Science Foundation of China(NSFC)projects(No.81271606);the Research Fund of Science and Technology Department of Jilin Province(Nos.201015185 and 201201041);the Research Fund of Shenzhen Sci-tech Department of Guangdong Province(No.201102154)
In this paper,the safety and efficacy of 131I-labeled mouse/human chimeric monoclonal antibody(131I-chTNT)-mediated radioimmunotherapy are evaluated because the patients have non-uptaking 131I pulmonary metastases fro...
Nature Science Foundation of Jilin Province (No200705277)
This work is to study the in vivo biological distribution of 131I-labeled mouse/human chimeric monoclonal antibody (131I-chTNT) in patients with pulmonary metastases from differentiated thyroid carcinoma. Ten patients...